HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Shozo Yamada Selected Research
Shozo Yamada Research Topics
Disease
59
Pituitary Neoplasms (Pituitary Adenoma)
02/2024 - 01/2002
56
Neoplasms (Cancer)
05/2024 - 01/2002
44
Adenoma (Adenomas)
03/2022 - 01/2002
19
Acromegaly
01/2023 - 08/2003
19
Pituitary ACTH Hypersecretion
06/2022 - 01/2002
16
ACTH-Secreting Pituitary Adenoma
02/2024 - 01/2005
8
Prolactinoma (Prolactinomas)
04/2022 - 12/2002
6
Growth Hormone-Secreting Pituitary Adenoma
05/2016 - 04/2003
4
Insulin Resistance
11/2017 - 10/2008
3
Carcinogenesis
09/2017 - 01/2002
3
Cushing Syndrome
09/2017 - 12/2006
3
Diabetes Mellitus
07/2013 - 12/2006
2
Cysts
05/2024 - 04/2014
2
Autoimmune Hypophysitis
01/2022 - 02/2018
2
Hemorrhage
01/2017 - 01/2004
2
Hyperthyroidism
01/2015 - 01/2009
2
Neoplasm Metastasis (Metastasis)
08/2013 - 12/2002
1
Craniopharyngioma (Craniopharyngiomas)
05/2024
1
Body Weight (Weight, Body)
11/2023
1
Proteinuria
01/2023
1
Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
01/2023
1
Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2022
1
Sarcoidosis (Schaumann Disease)
01/2022
1
Neurogenic Diabetes Insipidus (Central Diabetes Insipidus)
01/2022
1
Germinoma
01/2022
1
Hypopituitarism (Sheehan's Syndrome)
08/2021
1
Hyperprolactinemia
08/2021
1
False Aneurysm (Pseudoaneurysm)
01/2021
1
Teratoma (Teratoid Tumor)
07/2020
1
Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
07/2020
Drug/Important Bio-Agent (IBA)
29
Adrenocorticotropic Hormone (ACTH)
FDA Link
06/2022 - 01/2002
27
Growth Hormone (Somatotropin)
IBA
01/2023 - 01/2002
14
Hormones (Hormone)
IBA
07/2023 - 01/2003
12
Messenger RNA (mRNA)
IBA
12/2015 - 08/2003
11
Prolactin
IBA
03/2013 - 01/2003
10
Insulin-Like Growth Factor I (IGF-1)
IBA
01/2022 - 10/2008
8
Hydrocortisone (Cortisol)
FDA Link
Generic
02/2024 - 01/2002
8
Somatostatin (Somatotropin Release-Inhibiting Factor)
IBA
11/2022 - 06/2007
8
Transcription Factors (Transcription Factor)
IBA
04/2020 - 01/2002
7
Octreotide (Sandostatin)
FDA Link
Generic
11/2022 - 06/2007
7
Proteins (Proteins, Gene)
FDA Link
11/2022 - 01/2002
7
Glucose (Dextrose)
FDA Link
Generic
11/2016 - 12/2008
6
Temozolomide (Temodar)
FDA Link
Generic
04/2022 - 10/2009
6
Pro-Opiomelanocortin (Proopiomelanocortin)
IBA
01/2021 - 12/2007
6
DNA (Deoxyribonucleic Acid)
IBA
07/2018 - 04/2003
6
Cadherins (E-Cadherin)
IBA
01/2008 - 01/2002
5
Insulin (Novolin)
FDA Link
01/2022 - 12/2008
4
Dopamine Agonists (Dopamine Agonist)
IBA
04/2022 - 01/2009
4
Somatostatin Receptors (Somatostatin Receptor)
IBA
03/2022 - 06/2007
4
Catenins
IBA
06/2021 - 01/2002
4
Follicle Stimulating Hormone (Follitropin)
FDA Link
02/2020 - 03/2009
4
Thyrotropin (Thyroid-Stimulating Hormone)
FDA Link
02/2020 - 01/2009
4
Keratins (Keratin)
IBA
01/2013 - 01/2004
4
beta Catenin
IBA
01/2008 - 01/2002
3
Antibodies
IBA
01/2022 - 07/2013
3
Bromocriptine (Parlodel)
FDA Link
Generic
10/2014 - 01/2012
3
Anterior Pituitary Hormones
IBA
03/2013 - 01/2011
3
Protein Isoforms (Isoforms)
IBA
03/2012 - 04/2004
3
Fibroblast Growth Factors (Fibroblast Growth Factor)
IBA
03/2008 - 04/2004
3
gamma Catenin (Plakoglobin)
IBA
01/2004 - 01/2002
2
Metyrapone
FDA Link
02/2024 - 06/2021
2
Deamino Arginine Vasopressin (Desmopressin)
FDA Link
Generic
06/2022 - 01/2011
2
Capecitabine (Xeloda)
FDA Link
04/2022 - 01/2022
2
Glucocorticoids
IBA
06/2021 - 04/2014
2
Ubiquitin-Specific Proteases
IBA
01/2021 - 02/2016
2
MutS Proteins
IBA
04/2020 - 09/2017
2
Estradiol (Delestrogen)
FDA Link
Generic
02/2020 - 07/2019
2
Collagen
IBA
09/2017 - 12/2016
2
Glycated Hemoglobin (Glycosylated Hemoglobin)
IBA
05/2016 - 12/2008
2
Alkylating Agents
IBA
02/2016 - 03/2013
2
Corticotropin-Releasing Hormone
IBA
01/2015 - 01/2011
2
aryl hydrocarbon receptor-interacting protein
IBA
09/2014 - 04/2007
2
Methyltransferases
IBA
03/2013 - 10/2009
2
Dopamine D2 Receptors (Dopamine D2 Receptor)
IBA
01/2013 - 03/2012
2
Dopamine Receptors (Dopamine Receptor)
IBA
01/2011 - 01/2009
2
Vasopressin Receptors (Arginine Vasopressin Receptor)
IBA
01/2011 - 01/2011
2
Luteinizing Hormone (Lutropin)
FDA Link
Generic
03/2010 - 03/2009
2
Antigens
IBA
01/2010 - 01/2009
2
Type 4 Fibroblast Growth Factor Receptor
IBA
03/2008 - 09/2007
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2004 - 01/2003
1
Immune Checkpoint Inhibitors
IBA
02/2024
1
Sodium
IBA
11/2023
1
amsonic acid (DAS)
IBA
04/2022
1
Therapeutic Uses
IBA
04/2022
1
Oral Contraceptives
IBA
03/2022
1
somatostatin receptor 5
IBA
03/2022
1
pasireotide
IBA
03/2022
1
Testosterone (Sustanon)
FDA Link
08/2021
1
matrigel
IBA
06/2021
1
Dexamethasone (Maxidex)
FDA Link
Generic
06/2021
1
4-O-carboxymethylascochlorin
IBA
01/2021
1
B7-H1 Antigen
IBA
04/2020
Therapy/Procedure
10
Therapeutics
05/2024 - 10/2005
9
Radiotherapy
05/2024 - 01/2002
3
Aftercare (After-Treatment)
10/2014 - 12/2011
2
Adjuvant Radiotherapy
10/2017 - 05/2012
1
Immunotherapy
02/2024
1
Stents
01/2021
1
Chemoradiotherapy
07/2020
1
Drug Therapy (Chemotherapy)
07/2020